Bvf Inc Verve Therapeutics, Inc. Transaction History
Bvf Inc
- $2.67 Billion
- Q4 2024
A detailed history of Bvf Inc transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Bvf Inc holds 6,904,050 shares of VERV stock, worth $59.2 Million. This represents 1.46% of its overall portfolio holdings.
Number of Shares
6,904,050
Previous 650,000
962.16%
Holding current value
$59.2 Million
Previous $3.15 Million
1137.7%
% of portfolio
1.46%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding VERV
# of Institutions
179Shares Held
70.3MCall Options Held
124KPut Options Held
244K-
Alphabet Inc. Mountain View, CA12.3MShares$106 Million4.92% of portfolio
-
Black Rock Inc. New York, NY6.62MShares$56.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.01MShares$34.4 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY4MShares$34.3 Million1.94% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.92MShares$33.6 Million0.01% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $514M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...